Name
GS3-06 - PACE: Palbociclib After CDK and Endocrine Therapy A Randomized Phase I| Study of Fulvestrant +/ - Palbociclib after Progression on CDK4/6 inhibitor for HR+/HER2- Metastatic Breast Cancer
Date & Time
Wednesday, July 6, 2022
Speakers
Virtual Session Link